- Key Takeaways: The New VP of R&D's First 90 Days
- Before Day One: The Preparation Phase
- Days 1-30: Listen and Diagnose
- Days 31-60: Align and Decide
- Days 61-90: Act and Deliver
- The 90-Day Milestone Summary
- The Early Win: Choosing It Deliberately
- The Onboarding Mistake That Sinks New VP of R&Ds
- What the Organization Owes the Transition
- From 90 Days to the Full Tenure
- Frequently Asked Questions
As Global Head of Research & Leadership Advisory at JRG Partners, I offer this VP of R&D onboarding plan for the first 90 days for both the incoming executive and the leader receiving them. Executive transitions fail predictably, too fast on judgment, too slow on people, misread mandates, and this roadmap is built to design those failures out phase by phase.
Key Takeaways: The New VP of R&D’s First 90 Days
- The transition’s currency is credibility, earned through listening, honest assessment, and one early win, and spent on the harder changes that follow.
- Every phase should end in an artifact: the day-30 diagnosis, the day-60 plan agreed with the boss, the day-90 scorecard going live.
- Making one overdue kill decision, respectfully and with the resources visibly redeployed to a winner, resets the portfolio’s honesty.
- Onboarding is a two-party contract: the executive brings the plan below, and the organization brings mandate clarity, access, and patience calibrated in weeks, not days.
- New R&D VPs avoid early kills to preserve goodwill; the zombie programs they tolerate consume exactly the resources their priorities needed.
Before Day One: The Preparation Phase
Treat the pre-start window as phase zero: documents read, mandate written, stakeholder map drafted, and the first-week calendar built around listening rather than being presented to. The single highest-leverage artifact is a one-page mandate agreed with your manager before you start, because every later disagreement will be settled by whether it exists.
Days 1-30: Listen and Diagnose
Month one exists to establish truth: baseline, team, and terrain. The VP of R&D-specific diagnostic list:
- Review every program at working depth: data, not summaries
- Meet the scientists and engineers; the bench knows which programs are alive
- Audit the portfolio’s kill discipline history
- Assess external partnerships and CRO performance
- Map the budget against the strategy’s actual demands
Resist the pressure to announce. The organization is watching how you learn, and the quality of your questions in month one sets the credibility of your answers in month three.
Days 31-60: Align and Decide
Days 31-60 are for alignment and the decisions that cannot wait:
- Deliver the portfolio assessment with the advance/hold/kill calls framed
- Make the first kill decision if one is overdue; it defines the standard
- Reset stage-gate discipline with evidence requirements
- Address the organization gaps: leadership, capability, structure
Days 61-90: Act and Deliver
Days 61-90 convert agreement into evidence:
- Advance the priority programs visibly with resources concentrated
- Publish the portfolio strategy with the honest math
- Bank the milestone: a gate passed cleanly, a partnership signed, a technical wall broken
- Install the review rhythm with kill authority present
The 90-Day Milestone Summary
| Phase | Focus | Exit Artifact |
|---|---|---|
| Before day one | Mandate, materials, stakeholder map | Written mandate agreed with the hiring leader |
| Days 1-30 | Listening tour, baseline truth, team assessment | The honest diagnosis, delivered upward |
| Days 31-60 | Direction set, urgent people decisions, operating rhythm designed | The plan agreed, with resources and dates |
| Days 61-90 | Visible execution, first win, scorecard live | The early win delivered; the go-forward KPIs published |
The Early Win: Choosing It Deliberately
Choose the early win like an investment: maximum credibility per unit of risk, visible to the constituencies that matter, and bankable inside ninety days. For a VP of R&D, the pattern that works: Making one overdue kill decision, respectfully and with the resources visibly redeployed to a winner, resets the portfolio’s honesty. The wrong early win, flashy, contested, or hollow, costs more than none.
The Onboarding Mistake That Sinks New VP of R&Ds
New R&D VPs avoid early kills to preserve goodwill; the zombie programs they tolerate consume exactly the resources their priorities needed. Every new executive faces the standard hazards; this one is the role’s own, and knowing it in advance is most of avoiding it.
What the Organization Owes the Transition
The employer’s half of the contract: a written mandate, personally-made introductions to the stakeholders who matter, a named onboarding owner, air cover for the early decisions, and patience with the diagnosis phase. Organizations that hand new executives a laptop and a calendar invite, then wonder about slow starts, engineered them.
From 90 Days to the Full Tenure
The transition ends where the tenure’s measurement begins. The scorecard that goes live at day 90 should be the same one governing the tenure: our guide to measuring VP of R&D performance defines those KPIs and their cadence. And if the hire is still ahead of you, our VP of R&D interview questions guide tests for exactly the transition skills this roadmap demands.
Frequently Asked Questions
- Q: What should a new VP of R&D accomplish in the first 90 days?
- A: By day 90 the organization should have seen an honest assessment, an agreed plan, one meaningful delivered result, and the leader’s operating rhythm installed. Everything else is detail.
- Q: How long until a new VP of R&D reaches full productivity?
- A: Meaningful contribution starts inside the first month; full productivity, where the leader’s decisions drive the numbers, typically arrives between months four and nine depending on the role’s cycle time. Setting that expectation explicitly prevents both premature judgment and complacent drift.
- Q: What is the right early win for a new VP of R&D?
- A: Making one overdue kill decision, respectfully and with the resources visibly redeployed to a winner, resets the portfolio’s honesty. Choose for visibility, meaning, and deliverability inside the window, and deliver it before the honeymoon’s attention fades.
- Q: How quickly should a new VP of R&D make people changes?
- A: The evidence favors earlier than feels comfortable: teams already know who the problems are, and watching a new leader defer known calls reads as either blindness or weakness. Diagnose in month one, decide the clear cases by month two, execute with respect.
- Q: What if the job turns out different from the one described?
- A: Bring evidence to the next scheduled checkpoint and renegotiate the mandate in writing; a gap named at day 45 is a calibration, the same gap named at day 200 is a crisis with your name on it.
- Q: Who owns executive onboarding, HR or the hiring manager?
- A: The hiring manager, unambiguously, with HR building the process and the executive driving their own plan; the fastest way to predict a transition’s outcome is to ask who thinks they own it.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
